WearableDose

Company overview

WearableDose is a Bowie, Maryland medical technology company founded in 2023 and led by founder and CEO John B. Sanwo. It is developing a wearable radiation-sensing patch and connected software platform.

The company licenses polymer-based dosimeter technology developed at Sandia National Laboratories. Its oncology work aims to measure delivered radiation at the patient’s skin or beam-entry region and provide clinicians with dose information during treatment.

WearableDose also describes potential applications for first responders, defense personnel and radiation workers. Its clinical platform remains in development and validation while pursuing FDA clearance.

^[3][4][5]

Products & regulatory status How does MedTechIndex get this information?

Summary

WearableDose describes its platform as being in development and clinical validation while pursuing FDA clearance. John Sanwo’s June 2026 interview also describes work toward the Breakthrough Device Designation pathway; neither clearance nor designation is presented as granted. ^[3][1]

Sandia identifies WearableDose as the licensee of its polymer-based dosimeter technology. The wearable sensor and software are being developed for oncology dose verification, with additional radiation-safety applications. ^[2][3]

Regulatory snapshot How to read this snapshot

U.S. FDA

—

510(k) clearances

—

De Novo grants

—

PMA approvals

—

Recall events

Latest recorded source review: 2026-10-31.

Scope: selected product families.

Commercial portfolio snapshot

No commercially marketed product portfolio has been established in the reviewed material.

Commercial development

Radiation oncology dose monitoring

Wearable radiation dosimetry platform ↗

Flexible sensor patch and software platform under development for real-time radiation measurement at the skin or beam-entry region. The sensor generates an electrical signal in response to radiation, with data intended to support dose verification, clinician dashboards and alerts. Additional applications include radiation-worker, defense and emergency-response monitoring. ^[3][2][1]

Development and clinical validation · pursuing FDA clearance